BMC Actualizaciones e Información

Actualización de la política de no discriminación

Boston Medical Center Health System cumple con las leyes federales de derechos civiles aplicables y no discrimina por motivos de edad, raza, color, origen nacional (incluido el dominio limitado del inglés y el idioma principal), religión, cultura, discapacidades físicas o mentales, estatus socioeconómico, sexo, orientación sexual e identidad y/o expresión de género. BMCHS proporciona ayuda y servicios gratuitos a personas con discapacidades y servicios lingüísticos gratuitos a personas cuyo idioma principal no es el inglés.

Para leer nuestra Declaración de no discriminación completa, haga clic aquí.

Pulmonology, Allergy, Sleep, and Critical Care Medicine

Treatments and Services

Additional Diagnostic Testing

  • Echocardiography
  • Genetic testing
  • Pulmonary angiograms
  • Right heart catheterizations (at rest and with exercise)
  • Six-minute walk tests
  • Sputum culture testing

Additional Treatments

  • All 14 currently available medications for pulmonary arterial hypertension
  • CardioMEMS
  • Contact tracing of patients with active TB
  • Directly Observed Therapy (DOT) — a method of drug administration in which a health professional watches and provides support as a patient takes each dose of a medication, improving treatment adherence and completion
  • Education sessions on managing pulmonary conditions
  • Facilitation of lung transplants
  • Immunoglobulin replacement therapy
  • Management of complications related to TB medications
  • Medication for active tuberculosis
  • Mucus thinning medication
  • Oscillating positive expiratory pressure (PEP) devices
  • Oral or IV antibiotic therapy
  • Postural drainage
  • Precision immunomodulatory infusions
  • Prophylactic anti-infective agents
  • Individualized exercise program
  • Surgical resection
  • Treatment of bronchiectasis
  • Treatment of chronic liver disease Treatment of non-tuberculous mycobacterial lung infections
  • Treatment of COPD
  • Treatment of immune deficiency or sinus disease that may be associated with bronchiectasis
  • Treatment of latent (inactive) TB infections